Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 16 | ECE2008 | Next issue

10th European Congress of Endocrinology

Poster Presentations

Endocrine tumours

Previous section
Endocrine disruptors
Table of contents
Next section
Growth and development

ea0016p271 | Endocrine tumours

The comparison of serum VEGF levels between patients with metastatic and non-metastatic thyroid cancer, and patients with non-toxic multinodular goiter

ea0016p272 | Endocrine tumours

Special multiple endocrine neoplasia (MEN)

ea0016p273 | Endocrine tumours

The early results of the treatment of well differentiated thyroid cancer and its dependence on chosen factors

ea0016p274 | Endocrine tumours

Variability in rensponse to octreotide in patients with insulinoma detected by 111In-octreotide scintigraphy (Octreoscan)

ea0016p275 | Endocrine tumours

Nerve vagus schwannoma

ea0016p276 | Endocrine tumours

Use of multispine computed tomography in diagnostics of ectopic acth-syndrome

ea0016p277 | Endocrine tumours

Rottlerin inhibits migration of thyroid follicular carcinoma through destablization of the focal adhesion complex

ea0016p278 | Endocrine tumours

The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in large intestine metastases into liver

ea0016p279 | Endocrine tumours

PTHrP and HRG outcomes in MCF7 breast cancer cells transfected with HER receptors gene

ea0016p280 | Endocrine tumours

Type 1 iodothyronine deiodinase (D1) enzymatic activity is not reduced in liver focal nodular hyperplasia (FNH)

ea0016p281 | Endocrine tumours

An unusual case of painful gynaecomastia due to large adrenocortical tumour

ea0016p282 | Endocrine tumours

Screening of MEN1 gene in patients with either classic or variant MEN1 presentation

ea0016p283 | Endocrine tumours

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism in MEN-1 patients

ea0016p284 | Endocrine tumours

Correlation between postoperative hypothyroidism and seric homocysteine at the patients with thyroid carcinoma

ea0016p285 | Endocrine tumours

The role of parathyroid hormone-related protein on gynecomatia in patients with Klinefelter's syndrome and idiopathic gynecomastia

ea0016p286 | Endocrine tumours

Two new mutations in the RET protooncogene: R770Q in coincidence with Y791N in the same family with medullary thyroid carcinoma

ea0016p287 | Endocrine tumours

The role of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG/PET-CT) in the follow-up of differentiated thyroid cancer (DTC)

ea0016p288 | Endocrine tumours

Effects of the potent deacetylase inhibitor Panobinostat (LBH589) against poorly differentiated and anaplastic thyroid cancer cells

ea0016p289 | Endocrine tumours

Cytoplasmic shift of AUF1 in thyroid carcinoma

ea0016p290 | Endocrine tumours

Down-regulation of ENO1/MBP-1 gene products by retinoic acid (RA) causes decreased proliferation of the follicular thyroid carcinoma cell line FTC-133

ea0016p291 | Endocrine tumours

Differences in the gene expression patterns of several immune related genes in various human adrenocortical tumors

ea0016p292 | Endocrine tumours

Different gene expression patterns of histamine related genes in human adrenocortical tumors

ea0016p293 | Endocrine tumours

The prevalence of chosen complications in 72 acromegalics

ea0016p294 | Endocrine tumours

Expression of the somatostatin receptors (SSTRs) in patients with gastro-pancreatic neuroendocrine tumours (GEP-NET) and medullary thyroid cancers (MTC)

ea0016p295 | Endocrine tumours

Melatonin restores the basal level of lipid peroxidation in rat tissues under conditions of exposure to potassium bromate

ea0016p296 | Endocrine tumours

Relaxin and S100A4 alter the invasive potential in estrogen-independent human MDA-MB-231 breast cancer cells

ea0016p297 | Endocrine tumours

The Relaxin peptide is a novel regulator of S100A4 (metastasin) in thyroid carcinoma cells

ea0016p298 | Endocrine tumours

Cyclic Cushing disease: clinical case

ea0016p299 | Endocrine tumours

Adrenal ganglioneuroma: a new cause of increased serum calcitonin

ea0016p300 | Endocrine tumours

Proteomic profile of GH-secreting versus non-functioning pituitary tumors

ea0016p301 | Endocrine tumours

Genetic testing of RET protooncogene in multiple endocrine neoplasie type 2 and medullary thyroid carcinoma

ea0016p302 | Endocrine tumours

Impact of the use of recombinant TSH stimulated thyroglobulin measurement on health related quality of life in patients in follow-up for differentiated thyroid carcinoma (DTC)

ea0016p303 | Endocrine tumours

Cushings' syndrome due to ectopic ACTH secretion: four cases

ea0016p304 | Endocrine tumours

Inhibition of intracellular signaling pathways and induction of cell cycle arrest by the multi-kinase inhibitor sorafenib in thyroid carcinoma cells

ea0016p305 | Endocrine tumours

A rare case of hiperandrogenism bilateral Leydig cell tumor of the ovary

ea0016p306 | Endocrine tumours

Distinct catecholamine phenotypes in hereditary pheochromocytoma

ea0016p307 | Endocrine tumours

VDR gene polymorphisms in patients with differentiated thyroid cancer

ea0016p308 | Endocrine tumours

ERCC1 expression in adrenocortical carcinoma: relationship with baseline characteristics and response to platinum-based chemotherapy

ea0016p309 | Endocrine tumours

Leptin exerts apoptotic effects and regulates androgen receptors in human prostate cancer cells

ea0016p310 | Endocrine tumours

Long-term survival after surgical treatment in patients of adrenocortical carcinoma

ea0016p311 | Endocrine tumours

Parathyroid-hormone related- Peptide and PTHrP receptor type 1 are expressed in human adrenocortical carcinoma and regulate cell proliferation and apoptosis in H295R an adrenocortical-derived cell line

ea0016p312 | Endocrine tumours

Prognostic factors in localized adrenocortical carcinoma (ACC) after complete resection

ea0016p313 | Endocrine tumours

Multi-center, observational study on Sandostatin LAR treatment patients with acromegaly in Poland: preliminary report

ea0016p314 | Endocrine tumours

A study on investigations for localizing insulinoma

ea0016p315 | Endocrine tumours

Epidemiology of pituitary tumours in Iceland 1955--2007: a Nationwide Study

ea0016p316 | Endocrine tumours

Effects of pasireotide on bronchial carcinoids in primary culture

ea0016p317 | Endocrine tumours

The prognostic factors in adrenocortical carcinoma

ea0016p318 | Endocrine tumours

Cushing's syndrome due to a pigmented nodular adrenocortical disease and a acromegaly corresponding to a Carney complex (CNC)

ea0016p319 | Endocrine tumours

Self-observations of total life situation in patients with Acromegalia

ea0016p320 | Endocrine tumours

Mitotane induces a concentration-dependent impairment of platelet aggregation in patients with adrenocortical carcinoma

ea0016p321 | Endocrine tumours

One hundred minimally invasive parathyroidectomies without intraoperative localisation and PTH monitoring

ea0016p322 | Endocrine tumours

Effect of Ginkgo biloba extract supplementation on genotoxic damage after thyroid remnant ablation by 131I

ea0016p323 | Endocrine tumours

Neuroendocrine tumours (NETs): one centre experience

ea0016p324 | Endocrine tumours

Abnormalities in glucose tolerance in acromegalic patients

ea0016p325 | Endocrine tumours

Mutations in the ret proto-oncogene in Romanian patients with multiple endocrine neoplasia type 2

ea0016p326 | Endocrine tumours

Is the early postoperative hormonal assessment a helpful predictor of the long term remission in secreting pituitary adenomas after transsphenoidal adenomectomy?

ea0016p327 | Endocrine tumours

Prognostic value of 100 mcg s.c. octreotide test (SHort Octreotide Test – SHOT) for prediction of medical treatment outcome in patients with acromegaly

ea0016p328 | Endocrine tumours

Cushing syndrome with an atypical evolution

ea0016p329 | Endocrine tumours

Parathyroid carcinoma treated with cinacalcet: a preliminary report

ea0016p330 | Endocrine tumours

Ovarian serous and mucinous tumors of low malignant potential: patterns of stromal invasion

ea0016p331 | Endocrine tumours

Novel MEN1 germline mutations and clinical features in Greek patients with multiple endocrine neoplasia type 1

ea0016p332 | Endocrine tumours

Ghrelin and its receptor are present in an ectopic ACTH lung neuroendocrine tumour causing Cushing's syndrome: potential pathophysiological implications

ea0016p333 | Endocrine tumours

Deficits in the clinical management of patients with adrenocortical carcinoma in Germany

ea0016p334 | Endocrine tumours

The cAMP analog 8CL-cAMP enhances PKA RIIb, triggers apoptosis and blocks cells at S and G2 cell cycle phases after 4 days of treatment in the human adrenocortical cells H295R.

ea0016p335 | Endocrine tumours

Hyperprolactinaemia: different clinical expression in childhood

ea0016p336 | Endocrine tumours

G12/13-dependent growth of small cell lung cancer cells in vitro and in vivo

ea0016p337 | Endocrine tumours

High prevalence of pituitary adenomas: a cross-sectional study in the city of Banbury (Oxfordshire)

ea0016p338 | Endocrine tumours

Gastric NETs: new diagnostic and therapeutic approach

ea0016p339 | Endocrine tumours

Fenotypes in patients with Y791F mutation of RET protooncogene

ea0016p340 | Endocrine tumours

Insulin sensitivity in a patient with gastric ghrelinoma

ea0016p341 | Endocrine tumours

Association of genetic variants of somatostatin receptor 5 with acromegaly

ea0016p342 | Endocrine tumours

Cushing syndrome: cycling around diagnosis

ea0016p343 | Endocrine tumours

Raloxifene induces growth arrest and apoptosis in prostate cell lines expressing both ERα and β

ea0016p344 | Endocrine tumours

Pituitary adenomas: the reality of Braga

ea0016p345 | Endocrine tumours

Deregulated Wnt/β-catenin signaling in breast cancer: the LRP5Δ receptor

ea0016p346 | Endocrine tumours

p107Rbl1 is an haploinsufficient tumor suppressor in mouse pituitary

ea0016p347 | Endocrine tumours

Immunohistochemical evaluation of ghrelin expression in somatotroph and non-functioning pituitary tumours

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more